retatrutide cognitive benefits Perceived of treatment for obesity with retatrutide: A qualitative study of patients in a phase 2 clinical trial retatrutide cognitive effects Perceived benefits

Body composition and sarcopenia concerns have generated moderate but rapidly growing publication volume

The preferential fat loss likely results from glucagon receptor activation, which increases resting energy expenditure and promotes fat oxidation as the primary fuel source, sparing protein catabolism for energy needs

Nevertheless, it is associated with increased incidence of gastrointestinal adverse reactions [17]

Orforglipron has not yet been approved by regulators in the UK, US or Europe, though the US Food and Drug Administration is reviewing it

Based on the analysis above, despite the requirement of more clinical evidence, existing data has indicated the potential prospect for the use of GLP-1 and its analogues in AD treatment in the future (81)